Citi Reiterates a 'Buy' on DaVita Inc (DVA); Dialysis Final Rule Better than Proposed, but Not Perfect
Tweet Send to a Friend
Citi reiterates a 'Buy' rating on DaVita Inc (NYSE: DVA), raises price target from $72 to $75.
Citi analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst says ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
